Lymphocytopenia is a hallmark of severe disease in patients with COVID-19 (28), primarily involving T cells, both CD4+ and CD8+ lymphocytes (6, 23, 29, 30), which may account for the lower IFN-γ levels detected (23, 30). This evidence concerns the gene CD8A and lymphopenia.